inflamm
multicompon
respons
injuri
tissu
stress
infect
associ
diseas
occur
variou
tissu
organ
organ
clinic
two
main
categori
antiinflammatori
drug
steroid
drug
nonsteroid
antiinflammatori
drug
nsaid
steroid
drug
gener
refer
adrenocort
hormon
strong
antiinflammatori
effect
obviou
side
effect
watersodium
retent
puffi
osteoporosi
nsaid
one
wide
use
drug
world
mainli
classifi
salicyl
propion
acid
indol
fenam
acid
acet
acid
pyrazolon
howev
potenti
cardiovascular
gastrointestin
bleed
risk
due
strong
toxic
side
effect
mani
synthet
drug
tradit
chines
medicin
tcm
advantag
abund
resourc
definit
therapeut
effect
fewer
side
effect
discoveri
novel
antiinflammatori
drug
natur
compound
gradual
becom
research
hotspot
moutan
cortex
mc
dri
root
cortex
paeonia
suffruticosa
andrew
commonli
use
remov
blood
stasi
dredg
meridian
expel
pu
elimin
inflamm
tcm
prescript
pharmacolog
studi
show
mc
could
inhibit
product
tumor
necrosi
induc
lipopolysacchariderecombin
anim
experi
mc
could
significantli
decreas
level
cytokin
includ
macrophag
inflammatori
appar
inhibit
lpsinduc
acut
lung
injuri
rat
model
avail
evid
reveal
mc
potenti
inhibitori
activ
clinic
antiinflammatori
efficaci
howev
previou
studi
primarili
focus
singl
compon
integr
activ
compon
mechan
action
yet
fulli
clear
therefor
mainli
conduct
systemat
studi
potenti
inhibitor
mc
current
studi
dualluciferas
report
assay
integr
uplcqtofm
util
screen
potenti
inhibitor
mc
extract
antiinflammatori
activ
compon
confirm
vitro
experi
addit
mechan
activ
compound
predict
network
pharmacolog
method
gallic
acid
paeonol
paeoniflorin
purchas
macklin
biochem
co
ltd
shanghai
china
dexamethason
dex
obtain
sigma
chemic
co
st
loui
mo
usa
hplcgrade
formic
acid
purchas
meryer
chemic
technolog
co
ltd
shanghai
china
chemic
reagent
acetonitril
hypergrad
uplcqtofm
acquir
merck
kgaa
darmstadt
germani
polyethylenimin
pei
transient
transfect
reagent
purchas
polysci
carlsbad
ca
usa
report
assay
system
obtain
promega
madison
wi
usa
beta
human
elisa
kit
purchas
abcam
cambridg
uk
reagent
cell
cultur
obtain
biolog
industri
israel
mc
acquir
anguo
chines
herbal
medicin
market
identifi
professor
zhang
tiejun
tianjin
pharmaceut
research
institut
dri
mc
crush
powder
weigh
powder
accur
add
methanol
ultrason
extract
min
centrifug
collect
supernat
extract
dri
powder
vacuum
freezedri
hek
cell
purchas
american
type
cultur
collect
rockvil
md
usa
cultur
dmem
high
glucos
fb
iuml
penicillin
mgml
streptomycin
thermostat
incub
deriv
human
bronchial
epitheli
cell
also
purchas
american
type
cultur
collect
rockvil
md
usa
cultur
condit
hek
cell
except
ham
instead
dmem
high
glucos
hek
cell
cotransfect
luciferas
report
plasmid
pgl
promega
wi
usa
renilla
plasmid
h
cell
densiti
reach
pei
use
transfect
reagent
accord
manufactur
instruct
cell
randomli
assign
six
group
control
group
model
group
dex
moll
group
mch
mgml
group
mcm
mgml
group
mcl
mgml
group
cell
except
cell
control
group
stimul
tumor
necrosi
tnf
ngml
simultan
given
drug
h
among
dex
use
posit
control
could
decreas
express
hek
cell
rel
content
group
repres
rel
light
unit
rlu
ratio
follow
manufactur
instruct
water
acquiti
uplc
system
water
co
milford
usa
equip
photo
diod
array
detector
pdad
use
analyz
sampl
chromatograph
column
acquiti
beh
mm
mm
water
co
flow
rate
mlmin
column
temperatur
maintain
test
sampl
inject
volum
optim
mobil
phase
compos
formic
acid
water
b
acetonitril
ratio
follow
min
b
min
b
min
b
min
b
min
b
min
b
min
b
min
b
min
b
accur
mass
msm
measur
perform
water
qtof
micro
synapt
high
definit
mass
spectromet
water
ms
technolog
manchest
uk
dual
electrospray
ioniz
esi
system
optim
analyt
condit
set
follow
sourc
temperatur
capillari
voltag
kv
posit
ion
mode
kv
neg
ion
mode
sampl
extract
cone
voltag
v
v
respect
flow
rate
desolv
ga
lh
desolv
temperatur
cone
ga
flow
lh
ms
spectra
scan
rang
widepass
mode
da
da
leucin
enkephalin
amid
acet
lea
ngml
use
lock
mass
mh
mh
flow
rate
set
base
msm
inform
peak
interest
confirm
molecular
weight
structur
contain
constitu
peak
similar
msm
inform
could
identifi
differ
retent
behavior
freezedri
powder
mc
extract
accur
weigh
ultrason
dissolv
methanol
mgml
column
separ
fraction
transport
qtofm
system
compon
identif
fraction
collect
everi
min
deep
plate
vacuum
dri
residu
dissolv
dmem
dualluciferas
assay
oper
process
screen
fraction
could
reduc
level
perform
structur
analysi
dualluciferas
assay
system
use
verifi
antiinflammatori
activ
monomer
compound
oper
step
addit
human
elisa
kit
use
respect
measur
concentr
inflammatori
factor
cultur
supernat
cell
stimul
drug
absorb
sampl
measur
nm
use
biorad
model
micropl
reader
data
process
follow
instruct
elisa
kit
test
result
repres
mean
sem
ttest
use
comparison
signific
differ
among
differ
group
spss
statist
analysi
softwar
spss
inc
chicago
usa
use
statist
analysi
result
valu
p
consid
statist
signific
verifi
effect
mc
antiinflammatori
level
induc
hek
cell
investig
use
dualluciferas
report
assay
system
shown
figur
differ
dose
mc
mcl
mgml
mcm
mgml
mch
mgml
significantli
inhibit
product
also
show
dosedepend
inhibit
p
result
confirm
mc
contain
compon
potenti
antiinflammatori
activ
identifi
antiinflammatori
compon
mc
perform
dualluciferas
report
assay
integr
uplcqtofm
repres
chemic
compon
mc
total
ion
current
chromatogram
posit
neg
esi
mode
respect
shown
figur
b
total
seven
fraction
show
potenti
inhibitor
activ
figur
c
analyz
seven
fraction
compound
contain
identifi
exact
molecular
weight
diagnost
fragment
ion
figur
detail
result
msm
inform
shown
tabl
seven
potenti
inhibitor
could
classifi
two
type
accord
chemic
structur
monoterpen
oxypaeoniflorin
paeoniflorin
galloylpaeoniflorin
benzoyloxypaeoniflorin
mudanpiosid
c
phenol
acid
gallic
acid
paeonol
among
inhibitori
activ
galloylpaeoniflorin
benzoyloxypaeoniflorin
mudanpiosid
c
first
report
test
verifi
antiinflammatori
activ
monom
oxypaeoniflorin
galloylpaeoniflorin
benzoyloxypaeoniflorin
mudanpiosid
c
structur
characterist
paeoniflorin
mother
nucleu
structur
sinc
gener
drug
efficaci
mainli
depend
chemic
structur
select
paeoniflorin
mother
nucleu
four
compound
repres
compon
studi
antiinflammatori
activ
verif
inhibitori
activ
vari
concentr
moll
moll
moll
three
ingredi
gallic
acid
paeoniflorin
paeonol
chosen
dualluciferas
report
assay
shown
figur
gallic
acid
paeoniflorin
paeonol
show
signific
inhibitori
effect
verif
antiinflammatori
activ
gallic
acid
paeoniflorin
paeonol
concentr
gradient
moll
moll
moll
select
test
effect
express
induc
cell
shown
figur
three
compound
could
inhibit
overexpress
inflammatori
factor
dosedepend
manner
addit
result
also
illustr
correct
screen
method
transcript
factor
act
key
role
process
immun
respons
usual
activ
expos
inflammatori
cytokin
viral
infect
ultraviolet
irradi
physiolog
nonphysiolog
stimuli
howev
activ
signal
pathway
particip
immun
regul
inflamm
also
infect
cell
cycl
regul
cell
differenti
apoptosi
activ
elimin
time
may
lead
seriou
patholog
reaction
rheumatoid
arthriti
system
lupu
erythematosu
septic
shock
atherosclerosi
cancer
consequ
inhibitor
activ
primari
signific
protect
cell
potenti
damag
inflamm
base
effici
separ
analysi
function
uplcqtofm
cell
biolog
method
seven
compound
inhibitori
activ
screen
mc
among
gallic
acid
could
inhibit
activ
prevent
rela
acetyl
paeoniflorin
could
significantli
inhibit
reduc
express
phosphoryl
addit
paeonol
could
suppress
signal
block
signal
pathway
furthermor
oxypaeoniflorin
could
inhibit
elev
express
level
although
mechan
remain
unclear
addit
inhibitori
activ
galloylpaeoniflorin
benzoyloxypaeoniflorin
mudanosid
c
report
previou
studi
present
studi
three
compound
could
inhibit
activ
induc
tnfa
could
consid
novel
inhibitor
gener
efficaci
drug
depend
mainli
chemic
structur
accord
result
monoterpenoid
paeoniflorin
core
structur
may
also
inhibitori
activ
use
lead
compound
studi
innov
drug
furthermor
result
demonstr
antiinflammatori
activ
mc
relat
process
variou
compon
act
multipl
target
figur
consist
characterist
tcm
multipl
compon
multipl
pathway
multipl
target
addit
antiinflammatori
effect
mc
also
cytotox
cancer
cell
recent
research
show
mc
extract
could
reduc
cell
viabil
within
mgml
bladder
cancer
cell
treatment
h
paeonol
one
activ
ingredi
mc
ratio
apoptot
cell
reach
studi
demonstr
concentr
mgml
extract
mc
alreadi
antiinflammatori
activ
take
paeonol
exampl
show
signific
inhibitori
effect
concentr
moll
much
lower
toxic
content
find
agreement
character
drug
play
therapeut
role
certain
dose
rang
qualiti
marker
qmarker
repres
qualiti
tcm
take
content
certain
compon
index
also
abl
reflect
efficaci
consequ
determin
content
paeonol
approach
evalu
qualiti
mc
chines
pharmacopeia
unilater
accord
result
oxypaeoniflorin
paeoniflorin
galloylpaeoniflorin
benzoyloxypaeoniflorin
mudanpiosid
c
gallic
acid
paeonol
relat
antiinflammatori
effect
mc
could
consid
refer
standard
evalu
qualiti
mc
conclus
mc
show
signific
efficaci
inhibit
activ
seven
bioactiv
compon
screen
dualluciferas
report
assay
integr
uplcqtofm
accord
structur
characterist
potenti
inhibitor
could
categor
two
type
monoterpen
oxypaeoniflorin
paeoniflorin
galloylpaeoniflorin
benzoyloxypaeoniflorin
mudanpiosid
c
phenol
acid
gallic
acid
paeonol
thereinto
galloylpaeoniflorin
benzoyloxypaeoniflorin
mudanpiosid
c
first
report
effect
inhibit
activ
present
studi
demonstr
mc
contain
varieti
structur
divers
antiinflammatori
activ
ingredi
act
differ
target
provid
basi
discoveri
novel
antiinflammatori
drug
fewer
side
effect
articl
may
provid
use
refer
improv
qualiti
standard
mc
futur
addit
experiment
result
also
show
bioactivityintegr
uplcqtof
contain
chemic
bioactiv
detail
suitabl
screen
activ
ingredi
natur
medicin
